Pathological Response Following Neoadjuvant Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma: a Cross-Trial, Patient-Level Analysis
LANCET ONCOLOGY(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined